NO995500L - Use of a pharmaceutical composition for the treatment of / or prevention of ischemia - Google Patents
Use of a pharmaceutical composition for the treatment of / or prevention of ischemiaInfo
- Publication number
- NO995500L NO995500L NO995500A NO995500A NO995500L NO 995500 L NO995500 L NO 995500L NO 995500 A NO995500 A NO 995500A NO 995500 A NO995500 A NO 995500A NO 995500 L NO995500 L NO 995500L
- Authority
- NO
- Norway
- Prior art keywords
- ischemia
- prevention
- treatment
- pharmaceutical composition
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE9700415A BE1011151A3 (en) | 1997-05-13 | 1997-05-13 | Use of a pharmaceutical composition for treating and / or preventing ischemia. |
PCT/BE1998/000067 WO1998051291A1 (en) | 1997-05-13 | 1998-05-12 | Use of a pharmaceutical composition for treating and/or preventing ischemia |
Publications (2)
Publication Number | Publication Date |
---|---|
NO995500L true NO995500L (en) | 1999-11-10 |
NO995500D0 NO995500D0 (en) | 1999-11-10 |
Family
ID=3890512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO995500A NO995500D0 (en) | 1997-05-13 | 1999-11-10 | Use of a pharmaceutical composition for the treatment of / or prevention of ischemia |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0981339A1 (en) |
JP (1) | JP2001526658A (en) |
AU (1) | AU7327298A (en) |
BE (1) | BE1011151A3 (en) |
CA (1) | CA2287363A1 (en) |
NO (1) | NO995500D0 (en) |
WO (1) | WO1998051291A1 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2792203B1 (en) * | 1999-04-19 | 2003-05-16 | Mu Laboratoire | NOVEL COMPOSITION BASED ON NATURAL PLANT EXTRACTS, AND ITS USE, PARTICULARLY IN THE PHARMACEUTICAL OR COSMETIC FIELDS |
FR2796552A1 (en) * | 1999-07-21 | 2001-01-26 | Centre Nat Rech Scient | NOVEL USE OF BETA-NAPHTOQUINONE DERIVATIVES AND THEIR SALTS FOR THE MANUFACTURE OF MEDICINES HAVING AN INHIBITOR EFFECT ON THE RELEASE OF GLUTAMATE IN THE BRAIN |
FR2802425B1 (en) | 1999-12-21 | 2003-09-26 | Oreal | USE OF AN EXTRACT OF AT LEAST ONE PLANT FROM THE ERICACEAE FAMILY AS AN ANTI-GLYCATION AGENT |
EP1127572A3 (en) * | 2000-02-25 | 2003-05-02 | Basf Aktiengesellschaft | Use of flavones for treating cycloxygenase-2 mediated diseases |
FR2814950B1 (en) * | 2000-10-05 | 2003-08-08 | Oreal | USE OF AT LEAST ONE EXTRACT OF AT LEAST ONE PLANT FROM THE ERICACEAE FAMILY, IN COMPOSITIONS FOR TREATING SKIN SIGNS OF AGING |
DE10122714A1 (en) * | 2001-05-10 | 2002-11-21 | Brench Ag | Combination of a rutin and aescin for treating ocular disorders associated with altered blood circulation, e.g. glaucoma or edema |
DE10122715A1 (en) * | 2001-05-10 | 2002-11-21 | Brench Ag | Use of rutines and escines for the treatment of auricular circulatory disorders |
EP1382327A1 (en) * | 2002-07-17 | 2004-01-21 | Cognis France S.A. | Method of protection of the skin against ageing |
EP1382326A1 (en) * | 2002-07-17 | 2004-01-21 | Cognis France S.A. | Method of protecting the skin against ageing |
FR2844716B1 (en) * | 2002-09-23 | 2008-11-21 | Marcel Jacques Chicouri | NOVEL PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR FOR FOOD HYGIENE OF DIABETICS |
JP4562365B2 (en) * | 2003-09-19 | 2010-10-13 | 株式会社ノエビア | Health promotion composition |
EP1550450A1 (en) * | 2003-12-29 | 2005-07-06 | Boehringer Ingelheim International GmbH | Composition comprising an aqueous extract of red vine leaves and a blood circulating-improving agent for the treatment of chronic venous insufficiencies |
EP1588705A1 (en) * | 2004-04-21 | 2005-10-26 | INTE:LIGAND Software-Entwicklungs und Consulting GmbH | Use of coumarin derivatives |
EP1607006A1 (en) * | 2004-06-18 | 2005-12-21 | Unilever N.V. | Functional berry composition |
EP1959969A2 (en) * | 2005-07-01 | 2008-08-27 | The Johns Hopkins University | Compositions and methods for the treatment or prevention of disorders relating to oxidative stress |
FR2904222A1 (en) * | 2006-07-27 | 2008-02-01 | Sod Conseils Rech Applic | USE OF GINKGO BILOBA EXTRACTS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES |
KR100880876B1 (en) * | 2007-04-11 | 2009-01-30 | 경상대학교산학협력단 | Pharmaceutical composition for the prevention and treatment of the ischemia-reperfusion injury in the flaps or tissues containing anthocyanin extracted from the Black soybean seed coat |
DE102007033067A1 (en) * | 2007-07-13 | 2009-01-15 | Institut für Umweltmedizinische Forschung gGmbH | Preparations for improving the protection of human cells, in particular cells of the human skin against damaging influences by oxidative noxious agents and UV irradiation |
EP2014276A1 (en) | 2007-06-20 | 2009-01-14 | Cognis IP Management GmbH | Cosmetic compositions comprising sclareolide and hesperidin methyl chalcone |
MD3987C2 (en) * | 2009-09-03 | 2010-07-31 | Георге АНГЕЛИЧ | Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency |
MD3986C2 (en) * | 2009-09-23 | 2010-07-31 | Георге АНГЕЛИЧ | Use of Diosmine for the treatment of portal gastropathies in the hepatic cirrhosis |
MD4232C1 (en) * | 2012-11-08 | 2014-01-31 | Георге АНГЕЛИЧ | Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure |
MD4231C1 (en) * | 2012-11-08 | 2014-01-31 | Георге АНГЕЛИЧ | Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis |
CN110585222B (en) * | 2019-10-12 | 2023-05-09 | 西南医科大学 | Application of aescin compound in preparation of medicines |
IT202000010924A1 (en) * | 2020-05-13 | 2021-11-13 | Neilos S R L | "COMPOSITION FOR THE PREVENTION AND TREATMENT OF DISEASES OF THE CIRCULATORY SYSTEM AND RELATED SYMPTOMS" |
CN112138015B (en) * | 2020-10-22 | 2022-08-05 | 合肥博思科创医药科技有限公司 | Application of tribenoside in treating skin diseases caused by microcirculation disturbance |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3623255A1 (en) * | 1986-07-10 | 1988-01-21 | Oxo Chemie Gmbh | Pharmaceutical composition for preventing oxidative damage to blood vessels |
DE3808835A1 (en) * | 1987-03-27 | 1988-10-06 | Sandoz Ag | Pharmaceutical composition containing a mixture of dihydroergotamine, etilefrine and troxerutin |
FR2707495B1 (en) * | 1993-07-02 | 1995-09-01 | Roussel Uclaf | New use of beta-naphthoquinone derivatives and their salts. |
FR2726469B1 (en) * | 1994-11-08 | 1996-12-13 | Adir | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF FLAVONOIDS |
-
1997
- 1997-05-13 BE BE9700415A patent/BE1011151A3/en not_active IP Right Cessation
-
1998
- 1998-05-12 JP JP54862298A patent/JP2001526658A/en active Pending
- 1998-05-12 EP EP98920410A patent/EP0981339A1/en not_active Withdrawn
- 1998-05-12 CA CA002287363A patent/CA2287363A1/en not_active Abandoned
- 1998-05-12 AU AU73272/98A patent/AU7327298A/en not_active Abandoned
- 1998-05-12 WO PCT/BE1998/000067 patent/WO1998051291A1/en not_active Application Discontinuation
-
1999
- 1999-11-10 NO NO995500A patent/NO995500D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0981339A1 (en) | 2000-03-01 |
AU7327298A (en) | 1998-12-08 |
JP2001526658A (en) | 2001-12-18 |
BE1011151A3 (en) | 1999-05-04 |
WO1998051291A1 (en) | 1998-11-19 |
CA2287363A1 (en) | 1998-11-19 |
NO995500D0 (en) | 1999-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO995500D0 (en) | Use of a pharmaceutical composition for the treatment of / or prevention of ischemia | |
NO20006630D0 (en) | Pharmaceutical composition for the treatment of diabetes | |
DK0941103T3 (en) | Pharmaceutical preparation for the treatment of diabetes | |
IS2184B (en) | Oral oral dosage form | |
HUP0003851A3 (en) | Pharmaceutical composition for the treatment or prevention of glomerulopathy | |
DK0797991T3 (en) | Delayed-release drug formulation | |
NO20015782L (en) | Dietary composition or pharmaceutical composition for use in the prevention or treatment of hyperoxaluria | |
NO990594D0 (en) | Pharmaceutical surface aerosol composition | |
ID25543A (en) | ALPHA-ARIL-N-ALKINITRON AND THE PHARMACY COMPOSITION CONTAINING IT | |
FI973475A (en) | The composition and the product containing it | |
TR199800436A3 (en) | The use of primidine derivatives for cancer prevention. | |
BR9701673A (en) | Arrangement for the application of a medicinal liquid | |
NO985539D0 (en) | Pharmaceutical surface mixtures | |
NO995251D0 (en) | Procedure for administering halotherapy | |
DE69812708T2 (en) | NEW MEDICAMENT CONTAINING URIDINTRIPHOSPHATE | |
ITMI950855A0 (en) | PROCEDURE FOR THE PROTECTION OF STONE OR COVERING SURFACES | |
BR9806083A (en) | Pharmaceutical composition for the treatment of hapattite c | |
ID29294A (en) | PHARMACEUTICAL COMPOSITION | |
NO934832D0 (en) | Pharmaceutical composition for the prevention or treatment of arterioscerosis | |
ID25857A (en) | PHARMACEUTICAL COMPOSITION | |
ID18698A (en) | PHARMACEUTICAL COMPOSITION | |
ZA989238B (en) | Benzimidazole compounds pharmaceutical compositions containing the compounds and their use | |
NO983784D0 (en) | Processes for the preparation of biphenyl-isoxazole sulfonamides | |
NO993549L (en) | Imino-aza-anthracycline derivatives for the treatment of amyloidosis | |
GB9602444D0 (en) | Pharmaceutical compositions for the prevention or treatment of retrovirus infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |